Market Research Logo

Global Bacterial Conjunctivitis Drugs Market 2016-2020

About Bacterial Conjunctivitis Drugs

Bacterial conjunctivitis, which affects either one or both the eyes, is an extremely contagious eye condition wherein the conjunctiva is infected. Staphylococci, streptococci, gonococci, and Chlamydia are some of the causative agents of bacterial conjunctivitis. Extremely pathogenic bacteria such as Chlamydia trachomatis and Neisseria gonorrhea cause severe bacterial conjunctivitis. Antibiotics help in eradicating the microbes, resulting in faster clearance of the symptoms. Broad-spectrum antibiotics such as Besivance, Zymaxid, Maxitrol, and AzaSite, in the form of antibiotic pills, ointment, or eye drops help treat the infection. Fluoroquinolones, macrolides, aminoglycosides, and phenicols are among the different classes of antibiotics that are commonly prescribed to treat the condition.

Technavio’s analysts forecast the global bacterial conjunctivitis drugs market to grow at a CAGR of 2.77% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global bacterial conjunctivitis drugs market for 2015-2020. To calculate the market size, it considers revenue generated from the sales of branded and generic drugs along with over-the-counter (OTC) drugs used to treat bacterial conjunctivitis.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Bacterial Conjunctivitis Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Akorn
  • Alcon
  • Allergan
  • Bausch & Lomb
Other prominent vendors
  • Bayer
  • Daiichi Sankyo
  • F. Hoffmann-La Roche
  • InSite Vision
  • Merck
  • Nicox
  • Novartis
  • Perrigo
  • Pfizer
  • Santen Pharmaceutical
  • Shire
  • Valeant Pharmaceuticals
Market driver
  • Rising awareness about infections
  • For a full, detailed list, view our report
Market challenge
  • Patent expiry of drugs
  • For a full, detailed list, view our report
Market trend
  • Patient assistance programs
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global Bacterial Conjunctivitis Drugs Market 2016-2020

Technavio recognizes the following companies as the key players in the Global Bacterial Conjunctivitis Drugs Market: Akorn, Alcon, Allergan and Bausch & Lomb.

Other Prominent Vendors in the market are: Bayer, Daiichi Sankyo, F. Hoffmann-La Roche, InSite Vision, Merck, Nicox, Novartis, Perrigo, Pfizer, Santen Pharmaceutical, Shire and Valeant Pharmaceuticals.

Commenting on the report, an analyst from Technavio’s team said: “The patient assistance programs for conjunctivitis are expected to boost the growth of the market during the forecast period. Vendors are providing co-pay assistance to patients who purchase medications for conjunctivitis. For instance, Bausch & Lomb provides patient assistance programs for patients who are not covered by any private or government insurances. It provides assistance programs for drugs such as Besivance, Alrex, and Zylet, which are used to treat ophthalmic indications. Since the drug suppliers provide the assistance programs, patients are inclined toward buying branded therapies.”

According to the report, the rising awareness about conjunctivitis has resulted in an understanding about how to prevent and control the infection. This has been possible because of numerous awareness programs.

Further, the report states that Patent expiries result in the entry of generics, leading to a decline in the sales of branded drugs. The generics are usually just as effective and safe as the original drugs and come with the added advantage of lower costs. This will result in a major decline in the overall revenue of the market.

Companies Mentioned

Akorn, Alcon, Allergan and Bausch & Lomb, Bayer, Daiichi Sankyo, F. Hoffmann-La Roche, InSite Vision, Merck, Nicox, Novartis, Perrigo, Pfizer, Santen Pharmaceutical, Shire, Valeant Pharmaceuticals.

  • Executive summary
    • Highlights
  • Scope of the report
    • Market overview
    • Top-vendor offerings
      • Table Product offerings
  • Market research methodology
    • Research methodology
    • Economic indicators
  • Introduction
    • Key market highlights
  • Overview: Bacterial conjunctivitis
    • Conjunctivitis
      • Table Types of conjunctivitis
    • Bacterial conjunctivitis
      • Table Types of bacterial conjunctivitis
    • Signs and symptoms
      • Table Signs and symptoms of bacterial conjunctivitis
    • Diagnosis
    • Management
      • Table Drugs used to treat conjunctivitis
    • Economic burden
  • Pipeline analysis
    • Table Global bacterial conjunctivitis drugs market: Pipeline portfolio
    • FST-100
    • AzaSite Xtra (ISV-405)
  • Antimicrobial resistance
    • Table Causes of antimicrobial resistance
    • Initiatives to improve innovation of antibiotics
      • Table Initiatives improving antibiotic innovation
  • Legislation relating to antibiotic use in US
    • Table Legislation relating to antibiotic use in US
  • Market landscape
    • Market overview
    • Market size and forecast
      • Table Global bacterial conjunctivitis drugs market 2015-2020 ($ billions)
      • Table Snapshot of global bacterial conjunctivitis drugs market
    • Bacterial conjunctivitis drugs market in US
      • Table Percentage share of bacterial conjunctivitis drugs market in US
      • Table Bacterial conjunctivitis drugs market in US 2015-2020 ($ millions)
    • Five forces analysis
      • Table Five forces analysis
  • Market segmentation by drug class
    • Table Global bacterial conjunctivitis drugs market by drug class
    • Fluoroquinolones
    • Aminoglycosides
    • Macrolides
    • Other
  • Geographical segmentation
    • Global bacterial conjunctivitis drugs market by geography 2015-2020
      • Table Global bacterial conjunctivitis drugs market by geography 2015
      • Table Global bacterial conjunctivitis drugs market by geography 2015-2020 ($ billions)
    • Bacterial conjunctivitis drugs market in Americas
      • Table Bacterial conjunctivitis drugs market in Americas 2015-2020 ($ millions)
    • Bacterial conjunctivitis drugs market in EMEA
      • Table Bacterial conjunctivitis drugs market in EMEA 2015-2020 ($ millions)
    • Bacterial conjunctivitis drugs market in APAC
      • Table Bacterial conjunctivitis drugs market in APAC 2015-2020 ($ millions)
      • Table Global bacterial conjunctivitis drugs market: YoY growth and revenue based on geography 2015-2020
  • Market drivers
    • Table Key drivers
    • Rising awareness about infection
    • Development of multidrug-resistant variants
    • Prevalence of bacterial conjunctivitis
  • Impact of drivers
    • Table Impact of drivers
  • Market challenges
    • Table Key challenges
    • Patent expiry of drugs
    • Contentment with existing therapies
    • Adverse effects and limited efficacy of drugs
    • Weak R&D of drugs
  • Impact of drivers and challenges
    • Table Impact of drivers and challenges
  • Market trends
    • Table Key trends
    • Strategic alliances and M&A
    • Use of combination therapies
    • Patient assistance programs
  • Vendor landscape
    • Competitive scenario
    • Akorn
      • Table Akorn: YoY growth and revenues in ophthalmic segment 2011-2013 ($ millions)
      • Table Akorn: Key takeaways
    • Alcon
      • Table Business segmentation by revenue 2014
      • Table Alcon: YoY growth and revenue generated from sales of ophthalmic products 2011- 2014 ($ billions)
      • Table Alcon: Key takeaways
    • Allergan
      • Table Allergan: Key takeaways
    • Bausch & Lomb
      • Table Bausch & Lomb: Key takeaways
    • Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report